Provided by Tiger Trade Technology Pte. Ltd.

Liminatus Pharma LLC

5.16
-0.4700-8.35%
Post-market: 5.400.2400+4.65%19:51 EDT
Volume:117.26K
Turnover:639.16K
Market Cap:6.93M
PE:-0.29
High:5.88
Open:5.53
Low:5.15
Close:5.63
52wk High:203.00
52wk Low:4.75
Shares:1.34M
Float Shares:581.43K
Volume Ratio:0.99
T/O Rate:20.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.0650
EPS(LYR):-21.4999
ROE:--
ROA:-95.65%
PB:23.06
PE(LYR):-0.24

Loading ...

Liminatus Pharma Reports Reverse Stock Split

MT Newswires Live
·
Aug 19

Liminatus Pharma Sets 1-for-50 Reverse Stock Split Effective Aug. 20

Reuters
·
Aug 19

Liminatus Pharma, Inc. Announces Reverse Stock Split of Its Common Stock

THOMSON REUTERS
·
Aug 19

Liminatus Pharma - Announces 1-for-50 Reverse Stock Split

THOMSON REUTERS
·
Aug 19

Liminatus Pharma Q2 FY26 Net Loss Widens to $1.41 Million; Operating Loss Widens 23% to $1.38 Million

Reuters
·
Aug 15

Liminatus Pharma (LIMN) Stock Jumps Over 50% on a Listing Update

TIPRANKS
·
Aug 14

Liminatus Pharma Announces Transfer to NASDAQ Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

THOMSON REUTERS
·
Aug 13

Liminatus Pharma Moves NASDAQ Listing to Capital Market Tier

Reuters
·
Aug 13

Liminatus Pharma Annual Meeting Draws 48.31% of Shares Represented

Reuters
·
Aug 05

Liminatus Pharma Awaits NASDAQ Ruling After Saying Equity Tops $2.5 Million Threshold

Reuters
·
Jul 30

Liminatus Pharma Faces Potential NASDAQ Delisting After Failing $1 Minimum Bid Price Rule

Reuters
·
Jul 25

Liminatus Pharma Discloses Ewon Comfortech Initial Beneficial Ownership of 5.5 Million Shares

Reuters
·
Jul 07

Liminatus Pharma Amends Innocsai Merger Terms to Use Non-voting Convertible Preferred Stock

Reuters
·
Jul 06

NASD Most Active Issues

Dow Jones
·
Jul 03

Top Premarket Gainers

MT Newswires Live
·
Jul 02

Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Session (UPDATED)

Benzinga_recent_news
·
Jul 02

Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday

MT Newswires Live
·
Jul 01

Liminatus Pharma amends, restates merger agreement with InnocsAI

TIPRANKS
·
Jul 01

Liminatus Pharma Amends Innocsai Merger Terms, Targets July 2 Close

Reuters
·
Jul 01

Liminatus Pharma - Innocsai Equity Holders to Receive up to 19.99% of Liminatus Common Stock

THOMSON REUTERS
·
Jul 01